Valeant Offers to Buy Botox Maker Allergan

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Scarlet Fu reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change